This Fellowship programme, powered through our partnership with the Advanced Research + Invention Agency (ARIA), is one part of a much wider collaboration that is seeking to foster a diverse community of innovators from scientific, engineering, clinical, medical, and industry backgrounds – through engagement events, virtual communities, What If ideation, fellowships, proof-of-concept funds, and much more. Together, we aim to address the societal and economic challenges posed by neurological and neuropsychiatric disorders through scalable, cutting-edge neurotechnology solutions. By deliberately broadening participation and embracing speculative and practical ideas alike, the collaboration is dedicated to driving transformative impact and building a globally influential neurotech ecosystem.
Cambridge NeuroWorks, unites a distinguished consortium from Cambridge’s life sciences, technology, and business sectors. As an ARIA Activation Partner within ARIA’s Scalable Neural Interfaces opportunity space, this collaboration is dedicated to accelerating the development of next generation neurotechnologies to address critical conditions such as depression, dementia, chronic pain, epilepsy, and nervous system injuries.
Head over to Cambridge NeuroWorks to learn more about upcoming programmes.